Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 580 (ZNF580) is a protein known for its role as a sequence-specific transcription factor that binds double-stranded DNA[1][4]. It is primarily localized in the nucleoplasm of the cell and is involved in processes such as cellular responses to oxidative stress (hydrogen peroxide), positive regulation of cell migration, and enhanced production of the pro-inflammatory cytokine interleukin-8[1][4]. ZNF580 is particularly notable for its role in endothelial cells, where it regulates cell proliferation and migration and is implicated in mediating protective effects during ischemia–reperfusion injury by reducing apoptosis, stabilizing cell membrane integrity, and regulating autophagy through pathways such as PI3K/Akt and AMPK signaling[3]. Evidence suggests that ZNF580 may be involved in cardiovascular disease mechanisms and endothelial inflammation, making it a protein of interest in vascular biology, but it is not established as a classical therapeutic drug target such as a receptor or enzyme[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 580 (ZNF580).